您好,欢迎来到佐思信息
全国服务热线:
400-009-0050
佐思信息专注支持企业决策
您当前的位置:首页>>研究报告>>病患监测

2016-2026年全球血糖监测市场研究报告
Blood Glucose Monitoring Devices World Market Outlook 2016-2026: Glucose Test Strips, Self-Monitoring Blood Glucose Device, Non-Invasive Blood Glucose Meter, Continuous Blood Glucose Monitor

2016-2026年全球血糖监测市场研究报告
【报告编号】:No.25983
【发布时间】:2016-08
【关 键 字】:Blood Glucose Monitoring   血糖监测   
【报告页数】:165页
【报告价格】:电子版:2639美元
【交付方式】:Email发送或EMS快递
【订购热线】:


400-009-0050(全国24小时服务)
北京:010-82863481
上海:021-64871266 021-64872612

报告目录下载订购协议下载在线咨询

    专业、专注于为企业提供真正有价值的全球市场调查信息,是我们的使命。我们是中国第一家汇集全球众多行业研究机构研究成果的平台,致力于为企业决策提供最有效的市场资讯,特别是为中国企业了解和进入国际市场迈出第一步,提供全面的信息参考,我们跨越语言及时间的障碍,在信息爆炸的当下,努力为客户提供最有价值的全球产业资讯。我们公司也拥有独立的研究机构,聚焦于中国市场的研究,为国内外企业在中国市场大展宏图提供市场研究支持。

• 我们在全球的合作伙伴>>• 我们的研究中心>>

  • 英文摘要
  • 中文摘要
  • 索取简版报告
  • 病患监测行业的相关报告
DESCRIPTION
 
Medical devices are playing an increasingly important role in diabetes. Products such as blood glucose monitors and insulin pumps have now become the cornerstone for the management of blood glucose levels. At the moment, more invasive devices are being increasingly used in diabetes, such as those used in bariatric surgery. While such products continue to dominate the diabetes care devices market, there is a growing interest in innovative new technologies, such as non-invasive blood glucose monitoring and continuous glucose monitoring; which can offer regular blood glucose measurements (typically every few minutes). This is particularly useful as it provides greater insight into glucose levels throughout the day.
 
With technology continuing to advance and the prevalence of diabetes on the rise, the blood glucose monitoring market is set for major expansion in the next decade.
 
Forecasts in that Study - Overall World Market, Submarket, Product and Country
 
For the purpose of this report, the focus is self-monitoring blood glucose (SMBG) devices. The market size and forecast presented in the report are for SMBG devices. This report provides an overview of the SMBG devices market with a discussion of its segments, especially those that contribute to the development of the industry.
 
The report will focus on the four main segments of the market:
Glucose Test Strips
Glucose Meters
Continuous Glucose Monitoring
Accessories
 
Our work also shows individual revenue forecasts to 2026 for 12 national markets:
United States (US)
Japan
EU leaders - Germany, France, the UK, Italy and Spain (EU5)
BRIC nations - Brazil, Russia, India and China
Rest of the World (RoW)
 
 
Why Should You Read This Report
 
This comprehensive report will:
Enhance your strategic decision making
Assist with your research, presentations and business plans
Show which emerging market opportunities to focus on
Increase your industry knowledge
Keep you up-to-date with crucial market developments
Allow you to develop informed growth strategies
Build your technical insight
Illustrate trends to utilize
Strengthen your analysis of competitors
Provide risk analysis, helping you avoid the pitfalls other companies could make
Ultimately, help you to maximise profitability for your company.
How This Report Delivers
 
This 165 page report delivers:
Revenues for the Global Blood Glucose Monitoring Device Market to 2026 - assess that overall world blood glucose monitoring device market's potential and get forecasted revenues for the leading sub-classes:
Glucose Test Strips
Glucose Meters
Continuous Glucose Monitoring
Accessories
National market forecasting to 2026 provided for the US, EU5 (Germany, UK, France, Italy and Spain), Japan, China, India, Brazil, Russia and Rest of the World - explore the best regions for treatment demand, sales and growth
Companies, news and opinions - examine major players in this market and their main products, including Roche, Johnson & Johnson, Sanofi and Medtronic among others.
Two exclusive interviews with experts in this market:
Dr. Sara Bachmann, a senior physician at The Division of Endocrinology / Diabetology within the University Children's Hospital in Basel, Switzerland.
Bennet Dunlap, co- founder Diabetes Patient Advocacy Coalition (DPAC) a patient advocacy group that helps individuals with diabetes effect change in their local communities.
Analysis of what stimulates and restrains that industry and market - assess challenges and strengths there, helping you compete and gain advantages.
Main Questions Answered by This Analysis
 
How is the blood glucose monitoring device market evolving?
What is driving and restraining the blood glucose monitoring device market?
What are the market shares of the leading segments of the blood glucose monitoring devices market in 2015?
How will each blood glucose monitoring devices submarket grow over the forecast period and how much revenue will these submarkets account for in 2026?
How will the market shares for each blood glucose monitoring devices submarket develop from 2015-2026?
What is the value of the leading blood glucose monitoring devices segments in important regions of the world?
What will be the main driver of the overall market from 2015 to 2026?
Will leading national blood glucose monitoring devices markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
How will the market shares of the leading national markets change by 2026 and which country will lead the market in 2026?
How will the industry evolve during the period between 2016 and 2026?
Chapter Overviews - The Report's Structure
 
In summary, the chapters of this report cover the following topics:
Chapter 1 provides an overview of the main points of the report along with the research methods utilized by visiongain
 
Chapter 2 defines diabetes, symptoms, treatments, patient demographics and the types of diabetes monitoring devices being used today. There is also a brief section on the information on what diabetes monitoring test can show and the applications where a diabetes monitoring device can be used.
 
Chapter 3 explores the state of the SMBG devices market in 2015 and its future growth with a discussion on market trends in this industry.
 
Chapter 4 describes the glucose test strips market and assesses the growth of this sector during the forecast period 2015-2026, including market trends.
 
Chapter 5 describes the glucose meter market and assesses the growth of this sector during the forecast period 2015-2026, including market trends.
 
Chapter 6 describes the continuous glucose monitoring (CGM) market and assesses the growth of this sector during the forecast period 2015-2026, including market trends.
 
Chapter 7 discusses the profiles of the leading companies involved in the SMBG devices market.
 
Chapter 8 discusses the regional market forecasts of SMBG devices in the US, Japan, France, Germany, UK, Spain, Italy, Russia, Brazil, China and India, during the period 2015-2026.
 
Chapter 9 identifies strengths, weaknesses, opportunities and threats facing the industry and market. The main drivers and restraints are also described, in addition to the current issues facing the SMBG devices market between 2015 and 2026.
 
Chapter 10 contains the transcript of visiongain interview with Dr. Sara Bachmann, a senior physician at The Division of Endocrinology / Diabetology within the University Children's Hospital in Basel, Switzerland. As well as Bennet Dunlap, co- founder Diabetes Patient Advocacy Coalition (DPAC) a patient advocacy group that helps individuals with diabetes effect change in their local communities.
 
Chapter 11 is a summary of the report, highlighting conclusions from our research and analyses
 
Who Is That Study For?
Blood Glucose Monitoring Devices World Market Outlook 2016-2026: Glucose Test Strips, Self-Monitoring Blood Glucose Device, Non-Invasive Blood Glucose Meter, Continuous Blood Glucose Monitor will prove invaluable for anyone wanting to better understand the industry and its underlying dynamics. It will prove useful for businesses who wish to expand into different sectors or explore a new region for expansion of their existing operations. The report comprehensively lays out the market drivers, restraints, forecasts, technologies, investments, risks and trends to help the reader formulate a better-informed business strategy. This report will be ideal for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, Directors and others. Furthermore, governments, agencies and organisations will also find value in our research report.
 
visiongain is a trading partner with the US Federal Government.
 
Table of Contents
 
1. Executive Summary
1.1. Sector Highlights
1.2. Blood Glucose Monitoring Market Segmentation
1.3. Overview of Findings
1.4. Chapter Outline
1.5. Aims, Scope and Format of the Report
1.6. Who is This Report For?
1.7. Methodology
1.8. Research and Analysis Methods
1.9. Frequently Asked Questions (FAQ)
1.10. Glossary of Terms Related to the Report
1.11. About Visiongain
 
2. Introduction to Diabetes and Monitoring Devices
2.1. What is Diabetes?
2.1.1. Classifying Diabetes
2.1.2. Symptoms And Long-Term Complications
2.1.3. Treatment
2.1.4. Diagnosis
2.1.5. Diabetes on the global and public agenda
2.2. Diabetes Monitoring
2.2.1. Glucose Levels
2.2.2. Reagent Strips and Glucose Meters
2.2.3. Urine Testing
2.2.4. Haemoglobin A1c Testing
2.2.5. Blood Pressure
2.2.6. Blood Cholesterol
2.2.7. Eye Tests
 
3. The Global Self Monitoring Blood Glucose Devices Market, 2015-2026
3.1. The Global Diabetes Care Devices Market, 2015
3.2. SMBG Devices Market, 2015
3.3. Global SMBG Devices Market Forecast, 2015-2026
 
4. Glucose Test Strips Market, 2016-2026
4.1. Glucose Test Strips
4.2. Glucose Test Strips: Market Forecast, 2015-2026
4.2.1. Glucose Test Strips: Industry Trends, 2016-2026
4.3. Companies and Products
4.3.1. Abbott Diabetes Care
4.3.2. Bayer Healthcare
4.3.3. Roche
4.3.4. LifeScan
4.3.5. Nipro Diagnostics
 
5. Glucose Meters Market, 2016-2026
5.1. Glucose Meters
5.1.1. How It Works
5.2. Marketed Glucose Meters
5.3. Glucose Meters: Market Forecast, 2015-2026
5.3.1. Technology Advancements
5.3.2. Growing Significance of Emerging Markets
5.3.3. Blood Glucose Meters of Particular Interest
5.3.4. Emergence of CGMs
 
6. Continuous Glucose Monitoring Market, 2016-2026
6.1. Continuous Glucose Monitoring (CGM)
6.2. Continuous Glucose Monitoring Market, 2015
6.3. Continuous Glucose Monitoring (CGM) Systems vs. Fingertip Testing
6.3.1. The CGM Pipeline
6.4. Continuous Glucose Monitoring: Market Forecast, 2015-2026
6.5. Continuous Glucose Monitoring: Industry Trends, 2016-2026
6.5.1. Improved Glucose Control
6.5.2. The US is the Largest Market for CGMs
6.5.3. Challenges to Growth of CGMs
 
7. Leading Companies in the SMBG Devices Market, 2015
7.1. Market Showing Signs of Recovery
7.2. SMBG Devices Market: Breakdown By Company, 2015
7.3. Roche
7.3.1. Sales and Recent Performance Analysis
7.3.2. Roche Diagnostics
7.3.3. Marketed Glucose Meters
7.4. Abbott Laboratories
7.4.1. Sales and Recent Performance Analysis
7.4.2. Abbott Geographic Sales
7.4.3. Marketed Glucose Meters
7.5.1. Sales and Recent Performance Analysis, 2015
7.5.1.1. Medical Devices And Diagnostics (MD&D)
7.5.2. J&J Geographic Sales
7.5.3. Marketed Glucose Meters
7.6. Bayer Healthcare
7.6.1. Sales and Recent Performance Analysis, 2015
7.6.2. Bayer Healthcare Geographic Sales
7.6.3. Marketed Glucose Meters
7.7. Other Companies
 
8. Leading National SMBG Devices Markets, 2015-2026
8.1. Regional Breakdown of The Global Diabetes Monitoring Devices Market, 2015
8.2. The Global SMBG Devices Market: Regional Forecast, 2015-2026
8.3. US Medical Device Market
8.3.1. The US Market Forecast: 2015-2026
8.4. The European Market
8.4.1. Changes in the New EU Medical Device Regulations
8.4.2. Post Marketing Surveillance in the EU
8.4.3. Germany
8.4.4. France
8.4.5. Italy
8.4.6. Spain
8.4.7. UK
8.5. The Japanese Market
8.6. The BRIC Market
8.6.1. The Chinese Market
8.6.1.1. New Policies Favouring Domestically-Made Medical Devices
8.6.2. The Indian Market
8.6.3. The Russian SMBG Market
8.6.3.1. Russian SMBG Market Forecast 2015-2026
8.6.4. Brazilian Market Forecast, 2015-2026
8.6.4.1. Brazilian Market Forecast, 2015-2026
8.6.4.2. The Brazillian Market
 
9. SWOT Analysis of the SMBG Devices Market, 2016
9.1. SMBG Devices: Industry Trends
9.2. Strengths
9.2.1. Effective Disease Management
9.2.2. Technological Advancements
9.2.3. Patient Demographics
9.3. Weaknesses
9.3.1. Regulatory Board Approvals
9.3.2. Benefits Vs. Costs
9.3.3. Reimbursement Issues
9.4. Opportunities
9.4.1. Globalisation: Established and Emerging Markets
9.4.2. Next-Generation Blood Glucose Monitoring
9.4.3. Mobile Applications
9.5. Threats
9.5.1. “Burnout”: Issues with Testing Adherence
9.5.2. Decreasing Investments
 
10. Opinions from Our Industry Survey
10.1. Interview with Bennet Dunlap of The Diabetes Patient Advocacy Coalition (DPAC)
10.2. The Diabetes Patient Advocacy Coalition (DPAC)
10.3. Patient Safety
10.4. Market Drivers
10.5. Use of Generic Products
10.6. The Future of Blood Glucose Monitoring
10.7. Interview with Dr. Sara Bachmann of the Endocrinology and Diabetology Department; University Children's Hospital Basel
10.8. The Endocrinology and Diabetology Department; University Children's Hospital Basel
10.9. Patient Safety
10.10. Market Drivers
10.11. Use of Generic Products
10.12. The Future of Blood Glucose Monitoring
 
11. Conclusions
11.1. Overview
11.2. Glucose Test Strips will Remain the Largest Segment
11.3. Prominent Companies in the Market
11.4. World Market Forecasts
11.5. Future Outlook and Concluding Remarks
 
Associated Reports
Appendix A
Appendix B
 
List of Figures
Figure 1.1: Blood Glucose Monitoring Market Segmentation
Figure 3.1: The Global Diabetes Care Devices Market: Net Sales ($bn), By Sector, 2015
Figure 3.2: The Global Diabetes Care Devices Market: Market Shares (%), By Sector, 2015
Figure 3.3: SMBG Devices Market: Net Sales ($bn), By Product, 2015
Figure 3.4: SMBG Devices Market: Market Shares (%), By Product, 2015
Figure 3.5: Global SMBG Devices Market ($bn), AGR (%), 2015-2020
Figure 3.6: Global SMBG Devices Market ($bn), AGR (%), 2021-2026
Figure 4.1: Anatomy of a Blood Glucose Test Strip
Figure 4.2: Glucose Test Strips: Market Forecast ($bn), AGR(%), 2015-2020
Figure 4.3: Glucose Test Strips: Market Forecast ($bn), AGR (%), 2021-2026
Figure 5.1: Glucose Meters: Market Forecast ($bn), AGR (%), 2015-2020
Figure 5.2: Glucose Meters: Market Forecast ($bn), AGR (%), 2021-2026
Figure 5.3: Evolution of Blood Glucose Monitors
Figure 6.1: CGM Market: Net Sales ($m) By Product, 2015
Figure 6.2: CGM Market: Market Shares (%) By Product, 2015
Figure 6.3: CGM Devices: Market Forecast ($bn), AGR (%), 2015-2020
Figure 6.4: CGM Devices: Market Forecast ($bn), AGR (%), 2021-2026
Figure 7.1: Leading Companies in the SMBG Devices Market: Net Sales ($bn), 2015
Figure 7.2: Leading Companies in the SMBG Devices Market: Market Shares (%), 2015
Figure 7.3: Roche: Net Sales ($bn) By Sector, 2015
Figure 7.4: Roche: Market Shares (%) By Sector, 2015
Figure 7.5: Roche Diagnostics: Net Sales ($bn) By Sector, 2015
Figure 7.6: Roche Diagnostics: Market Shares (%) By Sector, 2015
Figure 7.7: Roche Diagnostics: Net Sales ($bn) By Region, 2015
Figure 7.8: Roche Diagnostics: Market Shares (%) By Region, 2015
Figure 7.9: Abbott: Net Sales ($bn) By Sector, 2015
Figure 7.10: Abbott: Market Shares (%) By Sector, 2015
Figure 7.11: Abbott: Net Sales ($bn) By Region, 2015
Figure 7.12: Abbott: Market Shares (%) By Region, 2015
Figure 7.13: Johnson & Johnson: Net Sales ($bn) By Segment, 2015
Figure 7.14: Johnson & Johnson: Market Shares (%) By Segment, 2015
Figure 7.15: J&J Medical Devices: Net Sales ($bn) By Segment, 2015
Figure 7.16: J&J Medical Devices & Diagnostics: Market Shares (%) By Segment, 2015
Figure 7.17: J&J Medical Devices & Diagnostics: Net Sales ($bn) By Region, 2015
Figure 7.18: J&J Medical Devices & Diagnostics: Market Shares (%) By Region, 2015
Figure 7.19: Bayer Group: Net Sales ($bn) By Segment, 2015
Figure 7.20: Bayer Group: Market Shares (%) By Segment, 2015
Figure 7.21: Bayer Healthcare: Net Sales ($bn) By Region, 2015
Figure 7.22: Bayer Healthcare: Market Shares (%) By Region, 2015
Figure 8.1: SMBG Devices Market: Sales ($bn) By Country, 2015
Figure 8.2: SMBG Devices Market: Market Shares (%) By Country, 2015
Figure 8.3: The US SMBG Devices Market Forecast ($bn), AGR (%), 2015-2026
Figure 8.4: The European SMBG Devices Market: Net Sales ($bn) By Region, 2015
Figure 8.5: The European SMBG Devices Market: Market Shares (%) By Region, 2015
Figure 8.6: The European SMBG Devices Market Forecast ($bn), AGR (%), 2015-2026
Figure 8.7: German SMBG Devices Market: Forecast ($bn), AGR (%), 2015-2026
Figure 8.8: French SMBG Devices Market Forecast ($bn), AGR (%), 2015-2026
Figure 8.9: The Italian SMBG Devices Market Forecast ($bn), AGR (%) 2015-2026
Figure 8.10: The Spanish SMBG Devices Market Forecast ($bn), AGR (%), 2015-2026
Figure 8.11: UK SMBG Devices Market Forecast ($bn), AGR (%), 2015-2026
Figure 8.12: Japan SMBG Devices Market Forecast ($bn), AGR (%), 2015-2026
Figure 8.13: The Chinese SMBG Devices Market Forecast ($bn), AGR (%), 2015-2026
Figure 8.14: The Indian SMBG Devices Market Forecast ($bn), AGR (%), 2015-2026
Figure 8.15: The Russian SMBG Devices Market Forecast ($bn), AGR (%), 2015-2026
Figure 8.16: The Brazilian SMBG Devices Market Forecast ($bn), AGR (%), 2015-2026
Figure 9.1: Google's Next-Generation Non-invasive Blood Glucose Monitor
Figure 9.2: Google's Next-Generation Non-invasive Blood Glucose Monitor: How it works
Figure 9.3: Diabetes Prevalence (%) in Leading National Markets, 2015
Figure 11.1: Projected SMBG Devices Market Growth Revenues ($bn), By Product
Figure 11.2: Projected Total SMBG Devices Market Size ($bn) In 2015, 2020 and 2026
 
List of Tables
Table 2.1: High Blood Glucose Age-Standardized Mortality Rates Per 100,000 (Age 20+)
Table 3.1: The Global Diabetes Care Devices Market: Net Sales ($bn), By Sector, 2015
Table 3.2: SMBG Devices Market: Net Sales ($bn) and Market Shares (%), By Product, 2015
Table 3.3: Global SMBG Devices Market, By Technology: Revenue ($bn), AGR (%) and CAGR (%), 2015-2020
Table 3.4: Global SMBG Devices Market, By Technology: Revenue ($bn), AGR (%) and CAGR (%) 2021-2026
Table 4.1: Glucose Test Strips: Market Forecast ($bn), 2015-2020
Table 4.2: Glucose Test Strips: Market Forecast ($bn), 2021-2026
Table 5.1: Top Marketed Glucose Meters, 2016
Table 5.2: Glucose Meters: Market Forecast ($bn), AGR (%), CAGR (%) 2015-2020
Table 5.3: Glucose Meters: Market Forecast ($bn) ), AGR (%), CAGR (%), 2021-2026
Table 5.4: Blood Glucose Monitoring Devices of Particular Interest
Table 6.1: CGM Market: Net Sales ($m) and Market Shares (%) By Product, 2015
Table 6.2: Advantages of CGMs over Fingerstick Testing Systems, 2016
Table 6.3: Marketed CGMs, 2016
Table 6.4: CGM Pipeline, 2016
Table 6.5: CGM Devices: Market Forecast ($bn), ), AGR (%), CAGR (%), 2015-2020
Table 6.6: CGM Devices: Market Forecast ($bn), ), AGR (%), CAGR (%), 2021-2026
Table 7.1: Leading Companies in the SMBG Devices Market: Net Sales ($bn) and Market Shares (%), 2015
Table 7.2: Roche: Net Sales ($bn) & Market Shares (%) By Sector, 2015
Table 7.3: Roche Diagnostics: Net Sales ($bn), Market Shares (%) By Sector, 2015
Table 7.4: Roche Diagnostics: Net Sales ($bn) and Market Shares (%) By Region, 2015
Table 7.5: Roche Diagnostics Glucose Meters, 2016
Table 7.6: Abbott: Net Sales ($bn), Market Shares (%) By Sector, 2015
Table 7.7: Abbott: Net Sales ($bn) and Market Shares (%) By Region, 2015
Table 7.8: Johnson & Johnson: Net Sales ($bn) & Market Shares (%) By Segment, 2015
Table 7.9: J&J Medical Devices: Net Sales ($bn) & Market Shares (%) By Franchise, 2015
Table 7.10: J&J Medical Devices & Diagnostics: Net Sales ($bn) & Market Shares (%) By Region, 2015
Table 7.11: LifeScan Glucose Meters, 2015
Table 7.12: Bayer Group: Net Sales ($bn) & Market Shares (%) By Segment, 2015
Table 7.13: Bayer Healthcare: Net Sales ($bn) & Market Shares (%) By Region, 2015
Table 7.16: Bayer Healthcare Glucose Meters, 2015
Table 7.17: Other Companies Operating in The Diabetes Monitoring Devices Market, 2015
Table 7.17: (contd.) Other Companies Operating in The Diabetes Monitoring Devices Market, 2015
Table 8.1: SMBG Devices Market: Sales ($bn) and Market Shares (%) By Country/Region, 2015
Table 8.2: SMBG Devices Market: Market Forecast ($bn) ), AGR (%), CAGR (%), Market Share (%), By Country/Region 2015-2026
Table 8.3: The Leading European SMBG Devices Markets: Market Value ($bn), European Market Shares (%) and Global Market Shares (%) By Region, 2015
Table 8.4: The European SMBG Devices Market Forecast By Region: Revenue ($bn), AGR (%), CAGR (%), 2015-2026
Table 8.5: German SMBG Devices Market: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
Table 8.6: France SMBG Devices Market: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
Table 8.7: Italy SMBG Devices Market: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
Table 8.8: Spain SMBG Devices Market: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
Table 8.9: UK SMBG Devices Market: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
Table 8.10: Japan SMBG Devices Market: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
Table 8.11: BRIC SMBG Devices Market: Revenue ($bn), AGR (%) and CAGR (%), Market Share of BRIC Region (%), 2015-2026
Table 8.12: China SMBG Devices Market: Revenue ($bn), AGR (%) and CAGR (%), Global Market Share (%), 2015-2026
Table 8.13: India SMBG Devices Market: Revenue ($bn), AGR (%) and CAGR (%), Global Market Share (%), 2015-2026
Table 8.14: Russia SMBG Devices Market: Revenue ($bn), AGR (%) and CAGR (%), Global Market Share (%), 2015-2026
Table 8.15: Brazil SMBG Devices Market: Revenue ($bn), AGR (%) and CAGR (%), Global Market Share (%), 2015-2026
Table 9.1: SWOT Analysis of the Global SMBG Devices Market, 2015-2026
Table 9.2: Diabetes Prevalence (m) in Leading National Markets, 2015
Table 9.3: Classification of Medical Devices in the United States
Table 11.1: SMBG Devices Market Forecast ($bn), AGR (%), CAGR (%), By Product, 2015, 2020 and 2026
 
Companies Listed
Abbott
Abbott Diabetes Care
Abbott Nutrition
AgaMatrix
Alere
All Medicus
Animas Corporation
Animas Corporation
Animas Corporation (Acquired by J&J)
Arkray
Bayer
Bionime
BioRad Laboratories
Boots
Braun
C8 MediSensors
Calibra Medical (acquired by J&J)
Cellnovo
Debiotech
Dexcom
Dexcom
Disetronic (Subsidiary of Roche)
Echo Therapeutics
EyeSense
Genesis Health Technologies
Hainice Medical
HoMedics
Johnson & Johnson
Johnson & Johnson Medical Limited
Lifescan
Livongo Health
Medingo (acquired by Roche)
Medtronic
Medtronic
Medtronic
Medtronic Diabetes
Mellitor
Nipro Diagnostics
Nova Biomedical
Omnis Health
Omron
Philosys
Positive ID
Prodigy Diabetes Care
Roche
Sanofi
Sensors for Medicine and Science
Siemens Healthcare
Tandem Diabetes Care
Verily
Walmart
Wockhardt
 
Other Organisations Mentioned
American Medical Devices and Diagnostic Association (AMDD)
China Food and Drug Administration (CFDA)
China's National Health and Planning Commission (NHPC)
Endocrinology and Diabetology Department, University Children's Hospital, Basel
Medical Devices Information & Technology Assistance Centre (MDITAC)
Medicines and Healthcare products Regulatory Agency (MHRA)
National Competent Authorities (NCAs)
National Diabetes Education Program (NDEP)
National Institute for Health and Clinical Excellence (NICE)
National Medical Devices Authority (NMDA)
NHS England
Pharmaceuticals and Medical Devices Agency (PMDA)
Technology Evaluation Centers (TEC)
The Diabetes Patient Advocacy Coalition
United States Food and Drug Administration (FDA)
US Department of Health and Human Services
World Bank
World Health Organization (WHO)

关于我们|联系我们|常见问题|服务项目|购买流程
2005-2013 All rights reserved.京ICP备05069564号-4 京公网安备110108 02010359号
全国服务热线:400-009-0050北京:010-82863481上海:021-64871266

在线客服系统